Immunohistochemical study of catecholamine enzymes and neuropeptide Y (NPY) in the rostral ventrolateral medulla and bulbospinal projection.
The purpose of this study was to determine whether neuropeptide Y (NPY) terminals in the intermediolateral spinal cord originate from the rostral ventrolateral medulla (RVLM). Immunohistochemical staining of tyrosine hydroxylase (TH), dopamine-beta-hydroxylase (DBH), phenylethanolamine-N-methyltransferase (PNMT), and NPY in the rat brainstem and spinal cord were performed in this study in order to examine consequences of lesions of the RVLM and of intracisternal injections of 6-hydroxydopamine (6-OHDA) on catecholamine and NPY immunoreactivity in the intermediolateral column (IML) of rats. In addition, ricin, a retrograde neurotoxin, was applied in the superior cervical ganglion (SCG) to determine its effect on catecholamine and NPY immunoreactivity in the IML. Computer-aided image analysis was used to quantify the immunohistochemical changes in the RVLM and spinal cord. The results demonstrated that many catecholamine- and NPY-containing neurons and/or fibers existed in the RVLM and their terminals were found in the IML. After administration of 6-OHDA intracisternally, the catecholamine and NPY immunoreactivities were decreased both in the brainstem and IML of the spinal cord. Following unilateral microinjection of 6-OHDA into the RVLM, the number of NPY- and catecholamine-containing neurons decreased and there was a reduction in neuron terminals on the ipsilateral side. After injection of ricin into the SCG, the catecholamine and NPY neurons of the medulla were not affected, whereas their terminals in the IML decreased ipsilaterally. These results indicate that most of the catecholamine- and NPY-immunoreactive terminals found in the IML originated in the RVLM. These terminals appear to project towards the superior cervical ganglia.
Tseng
C J
CJ
Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Lin
H C
HC
Wang
S D
SD
Tung
C S
CS
D000818:Animals; D001933:Brain Stem / Q000737:chemistry; D002395:Catecholamines / Q000032:analysis*; D004299:Dopamine beta-Hydroxylase / Q000032:analysis; D005728:Ganglia, Sympathetic / Q000737:chemistry / Q000187:drug effects; D007150:Immunohistochemistry; D008297:Male; D008526:Medulla Oblongata / Q000737:chemistry* / Q000166:cytology / Q000187:drug effects; D009478:Neuropeptide Y / Q000032:analysis*; D016627:Oxidopamine / Q000494:pharmacology; D010625:Phenylethanolamine N-Methyltransferase / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012276:Ricin / Q000494:pharmacology; D013116:Spinal Cord / Q000737:chemistry* / Q000166:cytology / Q000187:drug effects; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D002395:Catecholamines; D009478:Neuropeptide Y; D016627:Oxidopamine; D012276:Ricin; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase